Exhibit
23.2
Consent
of Independent Registered Public Accounting Firm
We
consent to the use of our report dated September 14, 2023, with respect to the financial statements of Tevogen Bio Inc, included
herein and to the reference to our firm under the heading “Experts” in the prospectus.
| /s/
KPMG LLP |
|
| Philadelphia, Pennsylvania |
|
| September 14, 2023 |
|